Search results
Raphael Rosenhek
Job title: Director Clinic for Valvular Heart Disease
Author
Lars Søndergaard
Research Area(s) / Expertise:
Author
Martin B Leon
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Martin B Leon
Added:
4 months ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic…
View more
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Anticoagulation after TAVI
Author(s):
Antonio Greco
,
Davide Capodanno
Added:
3 years ago
Article
Azfar Zaman
Research Area(s) / Expertise:
Author
Expertise
Trans-catheter Aortic Valve Implantation Guidelines - Does the Latest Evidence Change our Views?
Author(s):
Hannah McConkey
,
Bernard Prendergast
Added:
3 years ago
Article
TCT 2018: PORTICO-I
Author(s):
Lars Søndergaard
Added:
5 years ago
Video